Relationship between polypharmacy and activities of daily living or in-hospital falls in elderly patients hospitalized for proximal femoral fracture: A retrospective cohort study

Polypharmacy is a risk factor for falls and decreased functional ability in older adults; however, its age-specific impact during rehabilitation remains unclear. This study was conducted at Tsurugi Hospital, located in Ishikawa, Japan. This study aimed to investigate the association between polypharmacy and outcomes such as in-hospital falls and activities of daily living at discharge in elderly patients hospitalized for proximal femoral fractures, focusing on age-group differences. This retrospective cohort study was conducted at a comprehensive rehabilitation ward. Patients aged ≥75 years admitted between April 2020 and March 2022 were included in the study. Participants were stratified into 2 age groups (75-89 and ≥90 years). Polypharmacy was assessed using 2 definitions: ≥5 medications (conventional) and age group-specific median cutoffs. The functional independence measure (FIM) scores and fall incidence were analyzed using appropriate statistical methods, including multiple regression and Bonferroni correction. Eighty-six patients (mean age 89.3 ± 5.2 years) were analyzed. In the 75-89 years age group, polypharmacy defined as taking ≥8 medications at discharge was significantly associated with lower cognitive FIM scores (median: 23 vs 32; r = -0.384, P = .016). Subscale analyses revealed significant negative associations in comprehension (r = -0.463, P = .004), problem-solving (r = -0.325, P = .047), and memory (r = -0.360, P = .026). In the same age group, multiple regression analysis further confirmed that taking ≥9 medications at discharge was an independent predictor of lower cognitive FIM scores (β = -0.466, P = .003). In contrast, in the ≥90 years group, cognitive FIM scores were significantly negatively predicted by the presence of dementia (β = -0.376, P = .005). In the overall sample, body mass index (β = 0.284, P = .007) and shorter postoperative hospitalization duration (β = -0.274, P = .010) were also associated with better cognitive FIM scores. The relationship between polypharmacy and functional outcomes varied by age group. These findings highlight the need for individualized discharge planning and medication management based on patient age and background.

Authors

Institutions

Publication Details

Journal
Medicine
Published
2025-09-12
DOI
https://doi.org/10.1097/md.0000000000044481
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Relationship between polypharmacy and activities of daily living or in-hospital falls in elderly patients hospitalized for proximal femoral fracture: A retrospective cohort study

Eisuke Takeshima, Akira Kimura
Medicine
Pharmaceutical Practices and Patient Outcomes
article

Relationship between polypharmacy and activities of daily living or in-hospital falls in elderly patients hospitalized for proximal femoral fracture: A retrospective cohort study

Eisuke Takeshima, Akira Kimura
article en

Abstract

Polypharmacy is a risk factor for falls and decreased functional ability in older adults; however, its age-specific impact during rehabilitation remains unclear. This study was conducted at Tsurugi Hospital, located in Ishikawa, Japan. This study aimed to investigate the association between polypharmacy and outcomes such as in-hospital falls and activities of daily living at discharge in elderly patients hospitalized for proximal femoral fractures, focusing on age-group differences. This retrospective cohort study was conducted at a comprehensive rehabilitation ward. Patients aged ≥75 years admitted between April 2020 and March 2022 were included in the study. Participants were stratified into 2 age groups (75-89 and ≥90 years). Polypharmacy was assessed using 2 definitions: ≥5 medications (conventional) and age group-specific median cutoffs. The functional independence measure (FIM) scores and fall incidence were analyzed using appropriate statistical methods, including multiple regression and Bonferroni correction. Eighty-six patients (mean age 89.3 ± 5.2 years) were analyzed. In the 75-89 years age group, polypharmacy defined as taking ≥8 medications at discharge was significantly associated with lower cognitive FIM scores (median: 23 vs 32; r = -0.384, P = .016). Subscale analyses revealed significant negative associations in comprehension (r = -0.463, P = .004), problem-solving (r = -0.325, P = .047), and memory (r = -0.360, P = .026). In the same age group, multiple regression analysis further confirmed that taking ≥9 medications at discharge was an independent predictor of lower cognitive FIM scores (β = -0.466, P = .003). In contrast, in the ≥90 years group, cognitive FIM scores were significantly negatively predicted by the presence of dementia (β = -0.376, P = .005). In the overall sample, body mass index (β = 0.284, P = .007) and shorter postoperative hospitalization duration (β = -0.274, P = .010) were also associated with better cognitive FIM scores. The relationship between polypharmacy and functional outcomes varied by age group. These findings highlight the need for individualized discharge planning and medication management based on patient age and background.

MedicineVol. 104(37)
Gumma Paz College (JP), Hokuriku University (JP)
Openalex Percentile: Top 71%
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.